Global Hereditary Disease Carrier Screening Market Growth (Status and Outlook) 2026-2032
The global Hereditary Disease Carrier Screening market size is predicted to grow from US$ 2557 million in 2025 to US$ 4799 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 203... もっと見る
SummaryThe global Hereditary Disease Carrier Screening market size is predicted to grow from US$ 2557 million in 2025 to US$ 4799 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032.Hereditary Disease Carrier Screening is genetic testing used to identify whether an individual carries gene changes associated with inherited disorders that could be passed to a child. It is commonly offered before or during pregnancy to assess reproductive risk, especially for conditions that are inherited in an autosomal recessive or X linked manner. The results help guide next steps such as partner testing and genetic counseling so that individuals and couples can make informed reproductive decisions, while recognizing that a negative result reduces but does not eliminate risk because screening cannot detect every possible disease or genetic variant. United States market for Hereditary Disease Carrier Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Hereditary Disease Carrier Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Hereditary Disease Carrier Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Hereditary Disease Carrier Screening players cover Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. LPI (LP Information)' newest research report, the “Hereditary Disease Carrier Screening Industry Forecast” looks at past sales and reviews total world Hereditary Disease Carrier Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Hereditary Disease Carrier Screening sales for 2026 through 2032. With Hereditary Disease Carrier Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hereditary Disease Carrier Screening industry. This Insight Report provides a comprehensive analysis of the global Hereditary Disease Carrier Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hereditary Disease Carrier Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hereditary Disease Carrier Screening market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hereditary Disease Carrier Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hereditary Disease Carrier Screening. This report presents a comprehensive overview, market shares, and growth opportunities of Hereditary Disease Carrier Screening market by product type, application, key players and key regions and countries. Segmentation by Type: NGS Whole Exome Sequencing Others Segmentation by Screening Timing: Preconception Screening Prenatal Screening Segmentation by Screening Scope: Single-condition Screening Targeted multi-condition Screening Segmentation by Application: Couple Individual This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Thermo Fisher Scientific Eurofins Scientific Illumina Labcorp Quest Diagnostics MedGenome Myriad Genetics Natera OPKO Health 23andMe Mayo Clinic Laboratories Baylor Genetics GeneDx Fulgent Genetics NxGen MDx Sonic Genetics Ambry Genetics PreventionGenetics DiaSorin SYNLAB BGI Genomics Berry Genomics Annaroad Jiajian Medical Testing Genesky Weihansi Biomedical Technology Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Hereditary Disease Carrier Screening Market Size (2021-2032) 2.1.2 Hereditary Disease Carrier Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) 2.1.3 World Current & Future Analysis for Hereditary Disease Carrier Screening by Country/Region (2021, 2025 & 2032) 2.2 Hereditary Disease Carrier Screening Segment by Type 2.2.1 NGS 2.2.2 Whole Exome Sequencing 2.2.3 Others 2.2.4 Hereditary Disease Carrier Screening Market Size by Type 2.2.4.1 Hereditary Disease Carrier Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) 2.2.4.2 Global Hereditary Disease Carrier Screening Market Size Market Share by Type (2021-2026) 2.3 Hereditary Disease Carrier Screening Segment by Screening Timing 2.3.1 Preconception Screening 2.3.2 Prenatal Screening 2.3.3 Hereditary Disease Carrier Screening Market Size by Screening Timing 2.3.3.1 Hereditary Disease Carrier Screening Market Size CAGR by Screening Timing (2021 VS 2025 VS 2032) 2.3.3.2 Global Hereditary Disease Carrier Screening Market Size Market Share by Screening Timing (2021-2026) 2.4 Hereditary Disease Carrier Screening Segment by Screening Scope 2.4.1 Single-condition Screening 2.4.2 Targeted multi-condition Screening 2.4.3 Hereditary Disease Carrier Screening Market Size by Screening Scope 2.4.3.1 Hereditary Disease Carrier Screening Market Size CAGR by Screening Scope (2021 VS 2025 VS 2032) 2.4.3.2 Global Hereditary Disease Carrier Screening Market Size Market Share by Screening Scope (2021-2026) 2.5 Hereditary Disease Carrier Screening Segment by Application 2.5.1 Couple 2.5.2 Individual 2.5.3 Hereditary Disease Carrier Screening Market Size by Application 2.5.3.1 Hereditary Disease Carrier Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) 2.5.3.2 Global Hereditary Disease Carrier Screening Market Size Market Share by Application (2021-2026) 3 Hereditary Disease Carrier Screening Market Size by Player 3.1 Hereditary Disease Carrier Screening Market Size Market Share by Player 3.1.1 Global Hereditary Disease Carrier Screening Revenue by Player (2021-2026) 3.1.2 Global Hereditary Disease Carrier Screening Revenue Market Share by Player (2021-2026) 3.2 Global Hereditary Disease Carrier Screening Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Hereditary Disease Carrier Screening by Region 4.1 Hereditary Disease Carrier Screening Market Size by Region (2021-2026) 4.2 Global Hereditary Disease Carrier Screening Annual Revenue by Country/Region (2021-2026) 4.3 Americas Hereditary Disease Carrier Screening Market Size Growth (2021-2026) 4.4 APAC Hereditary Disease Carrier Screening Market Size Growth (2021-2026) 4.5 Europe Hereditary Disease Carrier Screening Market Size Growth (2021-2026) 4.6 Middle East & Africa Hereditary Disease Carrier Screening Market Size Growth (2021-2026) 5 Americas 5.1 Americas Hereditary Disease Carrier Screening Market Size by Country (2021-2026) 5.2 Americas Hereditary Disease Carrier Screening Market Size by Type (2021-2026) 5.3 Americas Hereditary Disease Carrier Screening Market Size by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Hereditary Disease Carrier Screening Market Size by Region (2021-2026) 6.2 APAC Hereditary Disease Carrier Screening Market Size by Type (2021-2026) 6.3 APAC Hereditary Disease Carrier Screening Market Size by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Hereditary Disease Carrier Screening Market Size by Country (2021-2026) 7.2 Europe Hereditary Disease Carrier Screening Market Size by Type (2021-2026) 7.3 Europe Hereditary Disease Carrier Screening Market Size by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Hereditary Disease Carrier Screening by Region (2021-2026) 8.2 Middle East & Africa Hereditary Disease Carrier Screening Market Size by Type (2021-2026) 8.3 Middle East & Africa Hereditary Disease Carrier Screening Market Size by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Hereditary Disease Carrier Screening Market Forecast 10.1 Global Hereditary Disease Carrier Screening Forecast by Region (2027-2032) 10.1.1 Global Hereditary Disease Carrier Screening Forecast by Region (2027-2032) 10.1.2 Americas Hereditary Disease Carrier Screening Forecast 10.1.3 APAC Hereditary Disease Carrier Screening Forecast 10.1.4 Europe Hereditary Disease Carrier Screening Forecast 10.1.5 Middle East & Africa Hereditary Disease Carrier Screening Forecast 10.2 Americas Hereditary Disease Carrier Screening Forecast by Country (2027-2032) 10.2.1 United States Market Hereditary Disease Carrier Screening Forecast 10.2.2 Canada Market Hereditary Disease Carrier Screening Forecast 10.2.3 Mexico Market Hereditary Disease Carrier Screening Forecast 10.2.4 Brazil Market Hereditary Disease Carrier Screening Forecast 10.3 APAC Hereditary Disease Carrier Screening Forecast by Region (2027-2032) 10.3.1 China Hereditary Disease Carrier Screening Market Forecast 10.3.2 Japan Market Hereditary Disease Carrier Screening Forecast 10.3.3 Korea Market Hereditary Disease Carrier Screening Forecast 10.3.4 Southeast Asia Market Hereditary Disease Carrier Screening Forecast 10.3.5 India Market Hereditary Disease Carrier Screening Forecast 10.3.6 Australia Market Hereditary Disease Carrier Screening Forecast 10.4 Europe Hereditary Disease Carrier Screening Forecast by Country (2027-2032) 10.4.1 Germany Market Hereditary Disease Carrier Screening Forecast 10.4.2 France Market Hereditary Disease Carrier Screening Forecast 10.4.3 UK Market Hereditary Disease Carrier Screening Forecast 10.4.4 Italy Market Hereditary Disease Carrier Screening Forecast 10.4.5 Russia Market Hereditary Disease Carrier Screening Forecast 10.5 Middle East & Africa Hereditary Disease Carrier Screening Forecast by Region (2027-2032) 10.5.1 Egypt Market Hereditary Disease Carrier Screening Forecast 10.5.2 South Africa Market Hereditary Disease Carrier Screening Forecast 10.5.3 Israel Market Hereditary Disease Carrier Screening Forecast 10.5.4 Turkey Market Hereditary Disease Carrier Screening Forecast 10.6 Global Hereditary Disease Carrier Screening Forecast by Type (2027-2032) 10.7 Global Hereditary Disease Carrier Screening Forecast by Application (2027-2032) 10.7.1 GCC Countries Market Hereditary Disease Carrier Screening Forecast 11 Key Players Analysis 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Information 11.1.2 Thermo Fisher Scientific Hereditary Disease Carrier Screening Product Offered 11.1.3 Thermo Fisher Scientific Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.1.4 Thermo Fisher Scientific Main Business Overview 11.1.5 Thermo Fisher Scientific Latest Developments 11.2 Eurofins Scientific 11.2.1 Eurofins Scientific Company Information 11.2.2 Eurofins Scientific Hereditary Disease Carrier Screening Product Offered 11.2.3 Eurofins Scientific Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.2.4 Eurofins Scientific Main Business Overview 11.2.5 Eurofins Scientific Latest Developments 11.3 Illumina 11.3.1 Illumina Company Information 11.3.2 Illumina Hereditary Disease Carrier Screening Product Offered 11.3.3 Illumina Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.3.4 Illumina Main Business Overview 11.3.5 Illumina Latest Developments 11.4 Labcorp 11.4.1 Labcorp Company Information 11.4.2 Labcorp Hereditary Disease Carrier Screening Product Offered 11.4.3 Labcorp Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.4.4 Labcorp Main Business Overview 11.4.5 Labcorp Latest Developments 11.5 Quest Diagnostics 11.5.1 Quest Diagnostics Company Information 11.5.2 Quest Diagnostics Hereditary Disease Carrier Screening Product Offered 11.5.3 Quest Diagnostics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.5.4 Quest Diagnostics Main Business Overview 11.5.5 Quest Diagnostics Latest Developments 11.6 MedGenome 11.6.1 MedGenome Company Information 11.6.2 MedGenome Hereditary Disease Carrier Screening Product Offered 11.6.3 MedGenome Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.6.4 MedGenome Main Business Overview 11.6.5 MedGenome Latest Developments 11.7 Myriad Genetics 11.7.1 Myriad Genetics Company Information 11.7.2 Myriad Genetics Hereditary Disease Carrier Screening Product Offered 11.7.3 Myriad Genetics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.7.4 Myriad Genetics Main Business Overview 11.7.5 Myriad Genetics Latest Developments 11.8 Natera 11.8.1 Natera Company Information 11.8.2 Natera Hereditary Disease Carrier Screening Product Offered 11.8.3 Natera Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.8.4 Natera Main Business Overview 11.8.5 Natera Latest Developments 11.9 OPKO Health 11.9.1 OPKO Health Company Information 11.9.2 OPKO Health Hereditary Disease Carrier Screening Product Offered 11.9.3 OPKO Health Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.9.4 OPKO Health Main Business Overview 11.9.5 OPKO Health Latest Developments 11.10 23andMe 11.10.1 23andMe Company Information 11.10.2 23andMe Hereditary Disease Carrier Screening Product Offered 11.10.3 23andMe Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.10.4 23andMe Main Business Overview 11.10.5 23andMe Latest Developments 11.11 Mayo Clinic Laboratories 11.11.1 Mayo Clinic Laboratories Company Information 11.11.2 Mayo Clinic Laboratories Hereditary Disease Carrier Screening Product Offered 11.11.3 Mayo Clinic Laboratories Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.11.4 Mayo Clinic Laboratories Main Business Overview 11.11.5 Mayo Clinic Laboratories Latest Developments 11.12 Baylor Genetics 11.12.1 Baylor Genetics Company Information 11.12.2 Baylor Genetics Hereditary Disease Carrier Screening Product Offered 11.12.3 Baylor Genetics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.12.4 Baylor Genetics Main Business Overview 11.12.5 Baylor Genetics Latest Developments 11.13 GeneDx 11.13.1 GeneDx Company Information 11.13.2 GeneDx Hereditary Disease Carrier Screening Product Offered 11.13.3 GeneDx Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.13.4 GeneDx Main Business Overview 11.13.5 GeneDx Latest Developments 11.14 Fulgent Genetics 11.14.1 Fulgent Genetics Company Information 11.14.2 Fulgent Genetics Hereditary Disease Carrier Screening Product Offered 11.14.3 Fulgent Genetics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.14.4 Fulgent Genetics Main Business Overview 11.14.5 Fulgent Genetics Latest Developments 11.15 NxGen MDx 11.15.1 NxGen MDx Company Information 11.15.2 NxGen MDx Hereditary Disease Carrier Screening Product Offered 11.15.3 NxGen MDx Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.15.4 NxGen MDx Main Business Overview 11.15.5 NxGen MDx Latest Developments 11.16 Sonic Genetics 11.16.1 Sonic Genetics Company Information 11.16.2 Sonic Genetics Hereditary Disease Carrier Screening Product Offered 11.16.3 Sonic Genetics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.16.4 Sonic Genetics Main Business Overview 11.16.5 Sonic Genetics Latest Developments 11.17 Ambry Genetics 11.17.1 Ambry Genetics Company Information 11.17.2 Ambry Genetics Hereditary Disease Carrier Screening Product Offered 11.17.3 Ambry Genetics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.17.4 Ambry Genetics Main Business Overview 11.17.5 Ambry Genetics Latest Developments 11.18 PreventionGenetics 11.18.1 PreventionGenetics Company Information 11.18.2 PreventionGenetics Hereditary Disease Carrier Screening Product Offered 11.18.3 PreventionGenetics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.18.4 PreventionGenetics Main Business Overview 11.18.5 PreventionGenetics Latest Developments 11.19 DiaSorin 11.19.1 DiaSorin Company Information 11.19.2 DiaSorin Hereditary Disease Carrier Screening Product Offered 11.19.3 DiaSorin Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.19.4 DiaSorin Main Business Overview 11.19.5 DiaSorin Latest Developments 11.20 SYNLAB 11.20.1 SYNLAB Company Information 11.20.2 SYNLAB Hereditary Disease Carrier Screening Product Offered 11.20.3 SYNLAB Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.20.4 SYNLAB Main Business Overview 11.20.5 SYNLAB Latest Developments 11.21 BGI Genomics 11.21.1 BGI Genomics Company Information 11.21.2 BGI Genomics Hereditary Disease Carrier Screening Product Offered 11.21.3 BGI Genomics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.21.4 BGI Genomics Main Business Overview 11.21.5 BGI Genomics Latest Developments 11.22 Berry Genomics 11.22.1 Berry Genomics Company Information 11.22.2 Berry Genomics Hereditary Disease Carrier Screening Product Offered 11.22.3 Berry Genomics Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.22.4 Berry Genomics Main Business Overview 11.22.5 Berry Genomics Latest Developments 11.23 Annaroad 11.23.1 Annaroad Company Information 11.23.2 Annaroad Hereditary Disease Carrier Screening Product Offered 11.23.3 Annaroad Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.23.4 Annaroad Main Business Overview 11.23.5 Annaroad Latest Developments 11.24 Jiajian Medical Testing 11.24.1 Jiajian Medical Testing Company Information 11.24.2 Jiajian Medical Testing Hereditary Disease Carrier Screening Product Offered 11.24.3 Jiajian Medical Testing Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.24.4 Jiajian Medical Testing Main Business Overview 11.24.5 Jiajian Medical Testing Latest Developments 11.25 Genesky 11.25.1 Genesky Company Information 11.25.2 Genesky Hereditary Disease Carrier Screening Product Offered 11.25.3 Genesky Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.25.4 Genesky Main Business Overview 11.25.5 Genesky Latest Developments 11.26 Weihansi Biomedical Technology 11.26.1 Weihansi Biomedical Technology Company Information 11.26.2 Weihansi Biomedical Technology Hereditary Disease Carrier Screening Product Offered 11.26.3 Weihansi Biomedical Technology Hereditary Disease Carrier Screening Revenue, Gross Margin and Market Share (2021-2026) 11.26.4 Weihansi Biomedical Technology Main Business Overview 11.26.5 Weihansi Biomedical Technology Latest Developments 12 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Hereditary Disease Carrier Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions) Table 2. Hereditary Disease Carrier Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of NGS Table 4. Major Players of Whole Exome Sequencing Table 5. Major Players of Others Table 6. Hereditary Disease Carrier Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions) Table 7. Global Hereditary Disease Carrier Screening Market Size by Type (2021-2026) & ($ millions) Table 8. Global Hereditary Disease Carrier Screening Market Size Market Share by Type (2021-2026) Table 9. Major Players of Preconception Screening Table 10. Major Players of Prenatal Screening Table 11. Hereditary Disease Carrier Screening Market Size CAGR by Screening Timing (2021 VS 2025 VS 2032) & ($ millions) Table 12. Global Hereditary Disease Carrier Screening Market Size by Screening Timing (2021-2026) & ($ millions) Table 13. Global Hereditary Disease Carrier Screening Market Size Market Share by Screening Timing (2021-2026) Table 14. Major Players of Single-condition Screening Table 15. Major Players of Targeted multi-condition Screening Table 16. Hereditary Disease Carrier Screening Market Size CAGR by Screening Scope (2021 VS 2025 VS 2032) & ($ millions) Table 17. Global Hereditary Disease Carrier Screening Market Size by Screening Scope (2021-2026) & ($ millions) Table 18. Global Hereditary Disease Carrier Screening Market Size Market Share by Screening Scope (2021-2026) Table 19. Hereditary Disease Carrier Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions) Table 20. Global Hereditary Disease Carrier Screening Market Size by Application (2021-2026) & ($ millions) Table 21. Global Hereditary Disease Carrier Screening Market Size Market Share by Application (2021-2026) Table 22. Global Hereditary Disease Carrier Screening Revenue by Player (2021-2026) & ($ millions) Table 23. Global Hereditary Disease Carrier Screening Revenue Market Share by Player (2021-2026) Table 24. Hereditary Disease Carrier Screening Key Players Head office and Products Offered Table 25. Hereditary Disease Carrier Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 26. New Products and Potential Entrants Table 27. Mergers & Acquisitions, Expansion Table 28. Global Hereditary Disease Carrier Screening Market Size by Region (2021-2026) & ($ millions) Table 29. Global Hereditary Disease Carrier Screening Market Size Market Share by Region (2021-2026) Table 30. Global Hereditary Disease Carrier Screening Revenue by Country/Region (2021-2026) & ($ millions) Table 31. Global Hereditary Disease Carrier Screening Revenue Market Share by Country/Region (2021-2026) Table 32. Americas Hereditary Disease Carrier Screening Market Size by Country (2021-2026) & ($ millions) Table 33. Americas Hereditary Disease Carrier Screening Market Size Market Share by Country (2021-2026) Table 34. Americas Hereditary Disease Carrier Screening Market Size by Type (2021-2026) & ($ millions) Table 35. Americas Hereditary Disease Carrier Screening Market Size Market Share by Type (2021-2026) Table 36. Americas Hereditary Disease Carrier Screening Market Size by Application (2021-2026) & ($ millions) Table 37. Americas Hereditary Disease Carrier Screening Market Size Market Share by Application (2021-2026) Table 38. APAC Hereditary Disease Carrier Screening Market Size by Region (2021-2026) & ($ millions) Table 39. APAC Hereditary Disease Carrier Screening Market Size Market Share by Region (2021-2026) Table 40. APAC Hereditary Disease Carrier Screening Market Size by Type (2021-2026) & ($ millions) Table 41. APAC Hereditary Disease Carrier Screening Market Size by Application (2021-2026) & ($ millions) Table 42. Europe Hereditary Disease Carrier Screening Market Size by Country (2021-2026) & ($ millions) Table 43. Europe Hereditary Disease Carrier Screening Market Size Market Share by Country (2021-2026) Table 44. Europe Hereditary Disease Carrier Screening Market Size by Type (2021-2026) & ($ millions) Table 45. Europe Hereditary Disease Carrier Screening Market Size by Application (2021-2026) & ($ millions) Table 46. Middle East & Africa Hereditary Disease Carrier Screening Market Size by Region (2021-2026) & ($ millions) Table 47. Middle East & Africa Hereditary Disease Carrier Screening Market Size by Type (2021-2026) & ($ millions) Table 48. Middle East & Africa Hereditary Disease Carrier Screening Market Size by Application (2021-2026) & ($ millions) Table 49. Key Market Drivers & Growth Opportunities of Hereditary Disease Carrier Screening Table 50. Key Market Challenges & Risks of Hereditary Disease Carrier Screening Table 51. Key Industry Trends of Hereditary Disease Carrier Screening Table 52. Global Hereditary Disease Carrier Screening Market Size Forecast by Region (2027-2032) & ($ millions) Table 53. Global Hereditary Disease Carrier Screening Market Size Market Share Forecast by Region (2027-2032) Table 54. Global Hereditary Disease Carrier Screening Market Size Forecast by Type (2027-2032) & ($ millions) Table 55. Global Hereditary Disease Carrier Screening Market Size Forecast by Application (2027-2032) & ($ millions) Table 56. Thermo Fisher Scientific Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 57. Thermo Fisher Scientific Hereditary Disease Carrier Screening Product Offered Table 58. Thermo Fisher Scientific Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 59. Thermo Fisher Scientific Main Business Table 60. Thermo Fisher Scientific Latest Developments Table 61. Eurofins Scientific Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 62. Eurofins Scientific Hereditary Disease Carrier Screening Product Offered Table 63. Eurofins Scientific Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 64. Eurofins Scientific Main Business Table 65. Eurofins Scientific Latest Developments Table 66. Illumina Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 67. Illumina Hereditary Disease Carrier Screening Product Offered Table 68. Illumina Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 69. Illumina Main Business Table 70. Illumina Latest Developments Table 71. Labcorp Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 72. Labcorp Hereditary Disease Carrier Screening Product Offered Table 73. Labcorp Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 74. Labcorp Main Business Table 75. Labcorp Latest Developments Table 76. Quest Diagnostics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 77. Quest Diagnostics Hereditary Disease Carrier Screening Product Offered Table 78. Quest Diagnostics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 79. Quest Diagnostics Main Business Table 80. Quest Diagnostics Latest Developments Table 81. MedGenome Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 82. MedGenome Hereditary Disease Carrier Screening Product Offered Table 83. MedGenome Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 84. MedGenome Main Business Table 85. MedGenome Latest Developments Table 86. Myriad Genetics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 87. Myriad Genetics Hereditary Disease Carrier Screening Product Offered Table 88. Myriad Genetics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 89. Myriad Genetics Main Business Table 90. Myriad Genetics Latest Developments Table 91. Natera Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 92. Natera Hereditary Disease Carrier Screening Product Offered Table 93. Natera Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 94. Natera Main Business Table 95. Natera Latest Developments Table 96. OPKO Health Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 97. OPKO Health Hereditary Disease Carrier Screening Product Offered Table 98. OPKO Health Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 99. OPKO Health Main Business Table 100. OPKO Health Latest Developments Table 101. 23andMe Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 102. 23andMe Hereditary Disease Carrier Screening Product Offered Table 103. 23andMe Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 104. 23andMe Main Business Table 105. 23andMe Latest Developments Table 106. Mayo Clinic Laboratories Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 107. Mayo Clinic Laboratories Hereditary Disease Carrier Screening Product Offered Table 108. Mayo Clinic Laboratories Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 109. Mayo Clinic Laboratories Main Business Table 110. Mayo Clinic Laboratories Latest Developments Table 111. Baylor Genetics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 112. Baylor Genetics Hereditary Disease Carrier Screening Product Offered Table 113. Baylor Genetics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 114. Baylor Genetics Main Business Table 115. Baylor Genetics Latest Developments Table 116. GeneDx Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 117. GeneDx Hereditary Disease Carrier Screening Product Offered Table 118. GeneDx Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 119. GeneDx Main Business Table 120. GeneDx Latest Developments Table 121. Fulgent Genetics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 122. Fulgent Genetics Hereditary Disease Carrier Screening Product Offered Table 123. Fulgent Genetics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 124. Fulgent Genetics Main Business Table 125. Fulgent Genetics Latest Developments Table 126. NxGen MDx Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 127. NxGen MDx Hereditary Disease Carrier Screening Product Offered Table 128. NxGen MDx Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 129. NxGen MDx Main Business Table 130. NxGen MDx Latest Developments Table 131. Sonic Genetics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 132. Sonic Genetics Hereditary Disease Carrier Screening Product Offered Table 133. Sonic Genetics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 134. Sonic Genetics Main Business Table 135. Sonic Genetics Latest Developments Table 136. Ambry Genetics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 137. Ambry Genetics Hereditary Disease Carrier Screening Product Offered Table 138. Ambry Genetics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 139. Ambry Genetics Main Business Table 140. Ambry Genetics Latest Developments Table 141. PreventionGenetics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 142. PreventionGenetics Hereditary Disease Carrier Screening Product Offered Table 143. PreventionGenetics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 144. PreventionGenetics Main Business Table 145. PreventionGenetics Latest Developments Table 146. DiaSorin Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 147. DiaSorin Hereditary Disease Carrier Screening Product Offered Table 148. DiaSorin Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 149. DiaSorin Main Business Table 150. DiaSorin Latest Developments Table 151. SYNLAB Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 152. SYNLAB Hereditary Disease Carrier Screening Product Offered Table 153. SYNLAB Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 154. SYNLAB Main Business Table 155. SYNLAB Latest Developments Table 156. BGI Genomics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 157. BGI Genomics Hereditary Disease Carrier Screening Product Offered Table 158. BGI Genomics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 159. BGI Genomics Main Business Table 160. BGI Genomics Latest Developments Table 161. Berry Genomics Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 162. Berry Genomics Hereditary Disease Carrier Screening Product Offered Table 163. Berry Genomics Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 164. Berry Genomics Main Business Table 165. Berry Genomics Latest Developments Table 166. Annaroad Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 167. Annaroad Hereditary Disease Carrier Screening Product Offered Table 168. Annaroad Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 169. Annaroad Main Business Table 170. Annaroad Latest Developments Table 171. Jiajian Medical Testing Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 172. Jiajian Medical Testing Hereditary Disease Carrier Screening Product Offered Table 173. Jiajian Medical Testing Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 174. Jiajian Medical Testing Main Business Table 175. Jiajian Medical Testing Latest Developments Table 176. Genesky Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 177. Genesky Hereditary Disease Carrier Screening Product Offered Table 178. Genesky Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 179. Genesky Main Business Table 180. Genesky Latest Developments Table 181. Weihansi Biomedical Technology Details, Company Type, Hereditary Disease Carrier Screening Area Served and Its Competitors Table 182. Weihansi Biomedical Technology Hereditary Disease Carrier Screening Product Offered Table 183. Weihansi Biomedical Technology Hereditary Disease Carrier Screening Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 184. Weihansi Biomedical Technology Main Business Table 185. Weihansi Biomedical Technology Latest Developments List of Figures Figure 1. Hereditary Disease Carrier Screening Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Hereditary Disease Carrier Screening Market Size Growth Rate (2021-2032) ($ millions) Figure 6. Hereditary Disease Carrier Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 7. Hereditary Disease Carrier Screening Sales Market Share by Country/Region (2025) Figure 8. Hereditary Disease Carrier Screening Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 9. Global Hereditary Disease Carrier Screening Market Size Market Share by Type in 2025 Figure 10. Global Hereditary Disease Carrier Screening Market Size Market Share by Screening Timing in 2025 Figure 11. Global Hereditary Disease Carrier Screening Market Size Market Share by Screening Scope in 2025 Figure 12. Hereditary Disease Carrier Screening in Couple Figure 13. Global Hereditary Disease Carrier Screening Market: Couple (2021-2026) & ($ millions) Figure 14. Hereditary Disease Carrier Screening in Individual Figure 15. Global Hereditary Disease Carrier Screening Market: Individual (2021-2026) & ($ millions) Figure 16. Global Hereditary Disease Carrier Screening Market Size Market Share by Application in 2025 Figure 17. Global Hereditary Disease Carrier Screening Revenue Market Share by Player in 2025 Figure 18. Global Hereditary Disease Carrier Screening Market Size Market Share by Region (2021-2026) Figure 19. Americas Hereditary Disease Carrier Screening Market Size 2021-2026 ($ millions) Figure 20. APAC Hereditary Disease Carrier Screening Market Size 2021-2026 ($ millions) Figure 21. Europe Hereditary Disease Carrier Screening Market Size 2021-2026 ($ millions) Figure 22. Middle East & Africa Hereditary Disease Carrier Screening Market Size 2021-2026 ($ millions) Figure 23. Americas Hereditary Disease Carrier Screening Value Market Share by Country in 2025 Figure 24. United States Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 25. Canada Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 26. Mexico Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 27. Brazil Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 28. APAC Hereditary Disease Carrier Screening Market Size Market Share by Region in 2025 Figure 29. APAC Hereditary Disease Carrier Screening Market Size Market Share by Type (2021-2026) Figure 30. APAC Hereditary Disease Carrier Screening Market Size Market Share by Application (2021-2026) Figure 31. China Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 32. Japan Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 33. South Korea Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 34. Southeast Asia Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 35. India Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 36. Australia Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 37. Europe Hereditary Disease Carrier Screening Market Size Market Share by Country in 2025 Figure 38. Europe Hereditary Disease Carrier Screening Market Size Market Share by Type (2021-2026) Figure 39. Europe Hereditary Disease Carrier Screening Market Size Market Share by Application (2021-2026) Figure 40. Germany Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 41. France Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 42. UK Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 43. Italy Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 44. Russia Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 45. Middle East & Africa Hereditary Disease Carrier Screening Market Size Market Share by Region (2021-2026) Figure 46. Middle East & Africa Hereditary Disease Carrier Screening Market Size Market Share by Type (2021-2026) Figure 47. Middle East & Africa Hereditary Disease Carrier Screening Market Size Market Share by Application (2021-2026) Figure 48. Egypt Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 49. South Africa Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 50. Israel Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 51. Turkey Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 52. GCC Countries Hereditary Disease Carrier Screening Market Size Growth 2021-2026 ($ millions) Figure 53. Americas Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 54. APAC Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 55. Europe Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 56. Middle East & Africa Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 57. United States Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 58. Canada Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 59. Mexico Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 60. Brazil Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 61. China Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 62. Japan Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 63. Korea Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 64. Southeast Asia Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 65. India Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 66. Australia Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 67. Germany Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 68. France Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 69. UK Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 70. Italy Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 71. Russia Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 72. Egypt Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 73. South Africa Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 74. Israel Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 75. Turkey Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions) Figure 76. Global Hereditary Disease Carrier Screening Market Size Market Share Forecast by Type (2027-2032) Figure 77. Global Hereditary Disease Carrier Screening Market Size Market Share Forecast by Application (2027-2032) Figure 78. GCC Countries Hereditary Disease Carrier Screening Market Size 2027-2032 ($ millions)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の 医療分野 での最新刊レポート
本レポートと同じKEY WORD(carrier)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|